Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Genetic Technologies, Promega; Cernostics; Invisible Sentinel; Massachusetts Life Sciences Center, North Shore InnoVentures, Covaris

NEW YORK (GenomeWeb News) – Genetic Technologies this week announced a settlement and licensing agreement with Promega. Under the terms of the deal, GTG granted Promega "broad rights" to GTG's Intron Sequence Analysis and Genomic Mapping patents. Financial and other terms were not disclosed.

GTG did not provide details about the dispute between it and Promega, but the Melbourne, Australia-based firm had previously claimed infringement by Promega of US Patent No. 5,612,179, held by GTG and covering methods of analyzing non-coding DNA sequences. GTG and Promega did not respond to requests for comment.

Ben Franklin Technology Partners of Northeastern Pennsylvania is investing $100,000 in cancer diagnostics firm Cernostics to validate a diagnostic and prognostic test being developed to predict the risk of developing esophageal cancer.

Invisible Sentinel's Veriflow Salmonella species assay has been certified by the Association of Analytical Communities for the detection of Salmonella contamination in multiple food types.

The Massachusetts Life Sciences Center awarded technology incubator and business accelerator North Shore InnoVentures a $1.65 million capital grant to expand its laboratory facilities and purchase analytical instruments. North Shore InnoVentures will use the funding to build out two new laboratories and add to an existing lab to accommodate four or five additional companies, it said. It added that it plans to acquire new capabilities in next-generation sequencing, mass spectrometry, digital PCR, flow cytometry, and cell imaging.

MLSC also awarded Covaris a grant to develop a one-step sample preparation device for use in molecular diagnostics as part of a $640,000 collaboration with Coris BioConcept. Covaris will develop its Adaptive Focused Acoustics sample prep technology to interface with Coris' novel detection technology for the early detection of sepsis. The amount of the grant was not disclosed.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Filed under